檢索結果 - Vittore Cereda

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen

    Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen 由 Cinzia Remondo, Vittore Cereda, Sven Mostböck, Helen Sabzevari, Alex Franzusoff, Jeffrey Schlom, Kwong-Y. Tsang

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio

    Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 由 Patrizia Ferroni, Silvia Riondino, Vincenzo Formica, Vittore Cereda, Livia Tosetto, Francesca Farina, Maria Giovanna Valente, Matteo Vergati, Fiorella Guadagni, Mario Roselli

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Effects of conventional therapeutic interventions on the number and function of regulatory T cells

    Effects of conventional therapeutic interventions on the number and function of regulatory T cells 由 Mario Roselli, Vittore Cereda, Maria Giovanna di Bari, Vincenzo Formica, Antonella Spila, Caroline Jochéms, Benedetto Farsaci, Renee N. Donahue, James L. Gulley, Jeffrey Schlom, Fiorella Guadagni

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

    Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant 由 Robert J. Lechleider, Philip M. Arlen, Kwong-Yok Tsang, Seth M. Steinberg, Junko Yokokawa, Vittore Cereda, Kevin Camphausen, Jeffrey Schlom, William L. Dahut, James L. Gulley

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination

    Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination 由 Matteo Vergati, Vittore Cereda, Ravi A. Madan, James L. Gulley, N. Y. Macy Huen, Connie J. Rogers, Kenneth W. Hance, Philip M. Arlen, Jeffrey Schlom, Kwong Y. Tsang

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

    Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma 由 James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin Jones, Mary Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert L. Kotz, William L. Dahut, Jeffrey Schlom

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

    Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer 由 James L. Gulley, Philip M. Arlen, Ravi A. Madan, Kwong-Yok Tsang, Mary Pazdur, Lisa Skarupa, Jacquin Jones, Diane J. Poole, Jack P. Higgins, James W. Hodge, Vittore Cereda, Matteo Vergati, Seth M. Steinberg, Susan Halabi, Elizabeth C. Jones, Clara Chen, Howard L. Parnes, James R. Wright, William L. Dahut, Jeffrey Schlom

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: